Skip links

The Evolution of NIST Cybersecurity Framework: Transitioning from 1.1 to Draft 2.0

Jump To Section

What is the Framework?

The Framework is voluntary guidance, based on existing standards, guidelines, and practices for organizations to better manage and reduce cybersecurity risk. In addition to helping organizations manage and reduce risks, it was designed to foster risk and cybersecurity management communications amongst both internal and external organizational stakeholders.

The Cybersecurity Framework Components: Core, Implementation Tiers, and Profiles

The Framework Core provides a set of desired cybersecurity activities and outcomes using common language that is easy to understand. The Core guides organizations in managing and reducing their cybersecurity risks in a way that complements an organization’s existing cybersecurity and risk management processes.

The Framework Implementation Tiers assist organizations by providing context on how an organization views cybersecurity risk management. The Tiers guide organizations to consider the appropriate level of rigour for their cybersecurity program and are often used as a communication tool to discuss risk appetite, mission priority, and budget.

Framework Profiles are an organization’s unique alignment of their organizational requirements and objectives, risk appetite, and resources against the desired outcomes of the Framework Core. Profiles are primarily used to identify and prioritize opportunities for improving cybersecurity at an organization.


Why is NIST deciding to transition from the Framework 1.1 to CSF 2.0? 

The NIST Cybersecurity Framework was intended to be a living document that is refined, improved, and evolves over time. These updates help the Framework keep pace with technology and threat trends, integrate lessons learned, and move best practice to common practice. NIST first produced the Framework in 2014 and updated it in April 2018 with CSF 1.1. Based on stakeholder feedback, and with a motive to include wider business verticals due to change in cybersecurity landscape and to help organizations more easily and effectively manage cybersecurity risk, NIST is working on a new, more significant update to the Framework: CSF 2.0. 

CSF 2.0

Currently we are at below step and final version will be release by early 2024

There are significant updates introduced on CSF draft 2.0:

  • New Function introduced i.e. Govern, and changes in the Category and Subcategories
Profiles and implementation Examples
  • Increased guidance on CSF implementation (Profiles and implementation Examples)
Framework Profile

Current and Target Profiles

Implementation Example

 Implementation Examples

  • Clarified understanding of cybersecurity measurement and assessment (see also NIST SP 800-55)
  • Emphasized cybersecurity supply chain risk management (C-SCRM) (see also NIST SP 800-161r1)
  • Alignment (and integration) with other Frameworks and standards. New references will be added later.
  • Recognition of the broad use of the Framework (New Title and wider scope to include small businesses)

CSF 1.1 

Title:“Framework for Improving Critical Infrastructure Cybersecurity”

CSF Draft 2.0

Title: “The NIST Cybersecurity Framework 2.0” 




 A new function “Govern” is Introduced

The framework (2.0) can be used to understand, assess, prioritize, and communicate about cybersecurity risks:

Understand and Assess:

  • Describe an organization’s current or target cybersecurity posture within and across organizations, sectors, or business units.
  • Determine where an organization may have cybersecurity gaps, including with respect to existing or emerging threats or technologies, and assess progress toward addressing those gaps.
  • Align policy, business, and technological approaches to managing cybersecurity risks across an entire organization or in a more focused area, such as a portion of the organization, a specific technology, or technology suppliers.


Prioritize opportunities to improve cybersecurity risk management.

  • Identify, organize, and prioritize actions for reducing cybersecurity risks that align with the organization’s mission, legal and regulatory requirements, and risk management and governance expectations.
  • Inform decisions about cybersecurity-related workforce needs and capabilities.


  • Provide a common language for communicating with internal and external parties about cybersecurity risks, capabilities, needs, and expectations.
  • Complement an organization’s risk management process by presenting a concise way for executives and others to distil the fundamental concepts of cybersecurity risk so that they express at a high-level risk to be managed and how their organization uses cybersecurity standards, guidelines, and practices.


NIST CSF 2.0 will become a milestone for a robust security framework of any organization. It has become more granular and easier to understand & implement. More n more cyber security professional will take advantage of it. Security Professionals are eagerly waiting for final version that will be released by early 2024. 

Shyam Kumar Thakur

Shyam Kumar Thakur

Latest Reads


Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes